Skip to main content
Clinical Trials/ITMCTR2200005625
ITMCTR2200005625
Completed
未知

A retrospective clinical study on the combination of traditional Chinese and Western medicine in the treatment of limited-disease small cell lung cancer

Guang'anmen Hospital, China Academy of Chinese Medicine Sciences0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Small-cell Lung Cancer
Sponsor
Guang'anmen Hospital, China Academy of Chinese Medicine Sciences
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Guang'anmen Hospital, China Academy of Chinese Medicine Sciences

Eligibility Criteria

Inclusion Criteria

  • (1\) The age ranges from 18 to 75 years.
  • (2\) Patients with localized SCLC with clear pathological diagnosis, following NCCN clinical guidelines, and receiving standardized treatment such as chest radiotherapy, chemotherapy, or prophylactic brain irradiation.
  • (3\) Survival time \> 3 months.
  • (4\) The integrated Chinese and Western medicine treatment group received TCM treatment \=6 months.

Exclusion Criteria

  • (1\) complicated with serious diseases of heart, liver, kidney and hematopoietic system.
  • (2\) other types of primary malignancy.
  • (3\) pregnant women, mental patients and patients suffering from other malignant tumors.
  • (4\) Patients who have participated in clinical trials of new drugs.
  • (5\) Absence of basic information.

Outcomes

Primary Outcomes

Not specified

Similar Trials